Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Gender-Stratified, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Two Vaccination Regimen With the Travelers' Diarrhea Vaccine System in Healthy Adults

NCT01067781 is registered in ClinicalTrials.gov with Intercell USA, Inc. as lead sponsor.

NCT NCT01067781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01067781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Gender-Stratified, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Two Vaccination Regimen With the Travelers' Diarrhea Vaccine System in Healthy Adults
Lead sponsor
Intercell USA, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
March 31, 2012
Enrollment
600 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea